8 tweets 11 reads Jan 11, 2025
Have you read:
"Impact of resistance training on cardiometabolic health-related indices in patients with type 2 diabetes and overweight/obesity: a systematic review and meta-analysis of randomised controlled trials"
Let's discuss the details...
@alexbatrakoulis New meta-analysis highlights the power of resistance training (RT) for managing type 2 diabetes (T2DM) and overweight/obesity. Here’s what you need to know about its cardiometabolic benefits: 🧡
@alexbatrakoulis The study analyzed 18 RCTs with 1180 participants (average age 63.3 years, BMI ~29.3 kg/mΒ²). Compared to standard care (no exercise), RT showed significant improvements in multiple health markers.
@alexbatrakoulis Key findings from resistance training:
‒↓ Waist circumference
‒↓ Waist-to-hip ratio
‒↓ Fasting blood glucose
‒↓ Fasting insulin
‒↓ HbA1c
‒↑ HDL cholesterol
‒↓ Triglycerides
@alexbatrakoulis The most common RT protocol:
β€’Duration: 12 weeks
β€’Frequency: 3x/week
β€’Session length: ~45 min
β€’60–70% of 1-rep max
β€’Whole-body routines with 3 sets of 12 reps per exercise
@alexbatrakoulis Why it matters:
Resistance training doesn’t just build strengthβ€”it’s a powerful tool for improving metabolic health in T2DM and overweight/obese patients.
@alexbatrakoulis Takeaway:
Incorporating RT into standard care for T2DM could improve patient outcomes significantly. It’s time to give resistance training the clinical attention it deserves!

Report this thread